Abstract
With population aging and the extension of life expectancy, the proportion of patients ≥ 75 years of age with ST-segment elevation myocardial infarction (STEMI) is expected to increase. As these elderly patients are at high risk of both ischemia and bleeding, giving the appropriate treatment to
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.